Effectiveness of medication self-management education programs for older adults: A systematic review

Article information

J Korean Gerontol Nurs. 2026;28(1):1-16
Publication date (electronic) : 2026 February 27
doi : https://doi.org/10.17079/jkgn.2025.00171
2026-02-27 1Associate Professor, Department of Nursing, Gangneung-Wonju National University, Wonju, Korea
2Postdoctoral Researcher, Department of Nursing, Gangneung-Wonju National University, Wonju, Korea
3Assistant Professor, Department of Nursing, Gangdong University, Eumseong, Korea
4Manager, Task Force for Clinical Trial Safety Support Department of Drug Safety Investigation, Anyang, Korea
5Administrative Officer, Public Health Center, Wonju, Korea
Corresponding author: SeongKwang Kim Department of Nursing, Gangneung-Wonju National University, 150 Namwon-ro, Heungeop-myeon, Wonju 26403, Korea. TEL: +82-33-760-8650 E-mail: ksk1677@naver.com
Received 2025 June 5; Revised 2025 October 29; Accepted 2026 February 20.

Abstract

Purpose

This systematic review evaluates the effectiveness of medication self-management education programs (MSEP) for older adults by analyzing the core characteristics and reported outcomes of successful interventions. Guided by King’s Goal Attainment Theory, this study identifies which program elements, such as scope, provider, and duration, are associated with positive clinical and psychosocial outcomes, aiming to provide evidence-based recommendations for practice and future research amid rising polypharmacy and inappropriate medication use.

Methods

A systematic review searched seven databases (up to September 3, 2024) for randomized controlled trials and quasi-experimental studies of medication self-management education for adults 65+. Inclusion followed PICOTS-SD (Participants, Intervention, Comparison, Outcomes, Time, Setting, and Study Design). Quality was assessed (RoB 2.0, ROBINS-I). Data were narratively synthesized, mapping program characteristics to King’s theory (e.g., interaction, transaction) to analyze goal attainment pathways.

Results

The 34 included studies demonstrated that MSEP are broadly effective in improving both clinical and psychosocial outcomes. Specifically, comprehensive, multi-session interventions were frequently associated with significant improvements in psychosocial outcomes such as quality of life and self-efficacy, particularly when delivered by multidisciplinary teams or nurses. In contrast, medication-specific programs (14 studies), often led by pharmacists, proved highly effective in enhancing key clinical outcomes, including medication adherence and the reduction of drug-related problems.

Conclusion

MSEP effectively enhance adherence. In accord with King’s Goal Attainment Theory, effectiveness is achieved via a ‘transactional’ process. Programs strong in ‘interaction’ (multi-session, nurse-led) achieve psychosocial ‘goal attainment’, while ‘action’-focused programs (pharmacist-led, specific) achieve clinical ‘goals’. The theory may underscore the need for tailored interventions.

BACKGROUND

1. Rationale for the Study

Over the past decades, pharmaceutical consumption has continuously increased due to aging of the population and the rise in chronic diseases [1]. According to Organisation for Economic Co-operation and Development (OECD) data, 48.6% of patients aged 75 and over are taking five or more medications as of 2021, with notably higher rates in some countries including Portugal (73.0%), Italy (64.7%), and South Korea (64.2%) [1].

Older adults typically take one or more prescribed medications due to chronic conditions such as hypertension, high cholesterol, and diabetes [2]. A study conducted in Italy analyzing more than 1.48 million older adults revealed that 54.2% experienced adverse effects from inappropriate medication use, resulting in a 16% increase in hospitalization risk [3]. According to the Centers for Disease Control and Prevention (CDC), approximately one-third of American adults in their 60s and 70s regularly use five or more prescription medications, which may increase the risk of overdose [4].

Inappropriate medication use, coupled with physical decline in older adults, reduces medication adherence and effectiveness. Older individuals experiencing cognitive decline may have difficulty managing medications due to issues such as forgetting dosages [5]. Various adverse effects may occur, including decreased attention, confusion, cognitive problems, falls and accidents, depression, and anxiety [2]. This represents a significant challenge in healthcare for older adults, emphasizing the need for careful adjustment of medication self-management and administration methods.

Differences in socioeconomic status and medical knowledge among older adults can lead to a high prevalence of potentially inappropriate medication [5]. This suggests the need for regular medication reviews and systematic, comprehensive, ongoing education to mitigate medication therapy-related risks in older adults. Such education can play a crucial role in helping older individuals perform safer and more appropriate medication self-management in relation to their health conditions.

Previous systematic reviews have highlighted the positive impact of medication self-management interventions for older adults. However, they also reported substantial variation in intervention design, duration, and outcome measures [6,7]. Various studies and efforts are ongoing worldwide to improve inappropriate medication use among older adults. For example, research using interventions such as nurse-led education on medication administration, medication self-management strategies, patient-tailored counseling, and follow-up phone calls to improve medication adherence in older patients with multiple conditions has successfully demonstrated significant effects on participants’ medication self-management [8]. Another study showed significant improvements in clinical outcomes as the number of older adults who reduced or discontinued sedative-hypnotic use increased through pharmacist-led medication education [9].

Previous research showed that a culturally tailored education program for Haitian immigrants diagnosed with hypertension demonstrated significant improvements in medication adherence and hypertension knowledge [10]. Six weeks after the intervention, participants showed a notable reduction in systolic and diastolic blood pressure, highlighting the potential impact of culturally sensitive educational approaches on managing chronic conditions effectively [10]. A study that developed and implemented a medication self-management education program (MSEP) significantly improved medication awareness and reduced medication misuse behavior in hypertensive patients [11]. Medication therapy management services have shown potential in reducing inappropriate medication use. However, the effectiveness of these services varies due to differences in design and short follow-up periods. Scoping reviews also emphasized the lack of a standardized educational approach for medication self-management among older adults [6,7].

A review of individual studies reveals that interventions for medication self-management in older adults vary widely in terms of delivery providers, educational content, frequency, and methods. Despite these differences, many studies reported positive changes, such as improved medication adherence and reduced misuse among older participants. This supports the potential benefit of education programs, even in the absence of a standardized approach. In particular, the significant effects shown by older recipients of interventions, such as improved medication adherence and reduced medication misuse behaviors, indicate the importance of medication self-management education. Therefore, this study aims to systematically review the existing literature on MSEP for older adults. By identifying and synthesizing the characteristics and outcomes of these interventions, this review seeks to inform the development of more effective and practical education programs tailored to the needs of older adults.

Previous systematic reviews have highlighted the positive impact of medication self-management interventions for older adults [6,7,9]. However, these studies also reveal significant gaps in the current understanding. For instance, some reviews found that the effects of certain programs, like medication therapy management, are often limited to short-term outcomes, leaving their long-term sustainability in question [6]. Others have mapped a wide array of available interventions without identifying a “gold standard,” which creates challenges for healthcare providers in selecting the most appropriate approach [7]. Furthermore, reviews focused on specific settings such as community pharmacies have shown inconsistent effects across different clinical outcomes, indicating that the success of an intervention is highly context-dependent [9]. A common limitation across these reviews is the substantial variation in intervention design and outcomes, often presented without a theoretical framework to explain why certain approaches might be more effective or how collaborative processes influence success.

This review addresses this gap by uniquely applying Imogene King’s Goal Attainment Theory as an analytical lens. This theoretical framework moves beyond a descriptive summary of intervention characteristics. It allows for a deeper analysis of the underlying dynamics of interaction and transaction between providers and older adults, offering a process-oriented explanation for achieving mutual goals. By systematically examining how program scope, provider type, and duration relate to specific clinical and psychosocial outcomes, this study offers novel insights into the mechanisms of successful self-management education. This approach provides a theory-informed understanding that helps to interpret the heterogeneity reported in prior reviews and to build a more robust evidence base for practice.

2. Research Objectives

This study aims to systematically evaluate the effectiveness of MSEP for older adults. The specific objectives are to: (1) synthesize the evidence on clinical and psychosocial outcomes of these programs; (2) analyze the characteristics of effective interventions, examining factors such as program scope (comprehensive vs. medication-specific), provider type (nurses, pharmacists, multidisciplinary teams), and duration (single-session vs. multi-session); and (3) identify key elements that contribute to successful goal attainment in medication self-management, guided by King’s Goal Attainment Theory.

3. Theoretical Framework

This study employs Imogene King’s Goal Attainment Theory [12] as an analytical framework to guide the systematic review of MSEP for older adults. King’s theory posits that goals are achieved through a dynamic process involving action, reaction, interaction, and transaction between healthcare providers and patients.

King’s Goal Attainment Theory is built upon interacting systems, primarily the personal system (individual characteristics such as perception, self-concept, and capacity for growth) and the interpersonal system (provider-patient dynamics involving communication, interaction, and collaborative transactions), which operate within a broader social system (healthcare organizational contexts). This review focuses specifically on how the personal and interpersonal systems contribute to the transaction process that leads to goal attainment.

To apply this framework to the systematic review, we operationalized these theoretical components by mapping the key characteristics of included studies as follows:

• The interpersonal system: The structure and process of provider-patient interactions were analyzed through program scope (comprehensive vs. medication-specific approaches), provider type (nurses, pharmacists, multidisciplinary teams), and program duration (single vs. multi-session interventions). These elements collectively define how the interaction and transaction phases unfold between providers and patients.

• The personal system: Individual patient factors and their influence on goal attainment were examined through the lens of patient characteristics and individual capacity factors as reported in the included studies.

• Goal attainment: The successful outcome of the transaction process was evaluated through both clinical outcomes (e.g., medication adherence, hospitalization rates) and psychosocial outcomes (e.g., self-efficacy, quality of life), representing the achievement of mutually established health goals.

By structuring the analysis through these theoretically-grounded dimensions, the framework allows for systematic interpretation of how different program characteristics contribute to the process of achieving medication self-management goals in older adults, moving beyond descriptive categorization to provide theoretical insights into the mechanisms of effective interventions.

METHODS

Ethics statement: This study was reviewed by the Institutional Review Board (IRB) of Gangneung-Wonju National University under the reference number GWNUIRB-R2024-25. The IRB determined that the study was exempt from ethical approval.

The protocol for this study is registered with PROSPERO (registration number: CRD42024533998), registered on 21/04/2024.

1. Study Design

This systematic review examines MSEP for older adults, identifying key characteristics and synthesizing implementation and outcome findings. It adheres to the Cochrane Handbook for Systematic Reviews of Interventions (version 6.5.0) [13] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines [14].

2. Literature Inclusion and Exclusion Criteria

Specific inclusion criteria were established according to the PICOTS-SD framework (Participants, Intervention, Comparison, Outcomes, Time, Setting, and Study Design). However, in this review, no specific restrictions were imposed on ‘outcomes’, ‘time’, or ‘setting’. The ‘participants’ criterion included adults aged 65 and over [15] (or studies explicitly describing participants as older adults). For the ‘intervention’, only studies involving medication self-management programs or education addressing adherence, polypharmacy, misuse, or abuse were considered. In terms of ‘comparison’, eligible studies had to include a control group (receiving usual care or alternative interventions). The ‘study design’ was limited to randomized controlled trials (RCTs) or quasi-experimental studies with pre-post measurement.

Studies were excluded if they did not target older adults—defined as studies that did not explicitly state that participants were older adults or had a mean/median age below 65 (except when the study explicitly designated the target population as older adults despite including younger participants). Studies were also excluded if the intervention was not primarily a medication self-management (education) program, if there was no control group, or if the study was not an experimental study designed to evaluate effectiveness (e.g., proceedings or procedure studies). In addition, studies that did not report analyzable data (such as statistical outcomes), studies from the gray literature, case reports, qualitative studies, literature reviews, and meta-analyses were excluded. Finally, studies for which the full text was unavailable or that were duplicate publications were also excluded.

3. Literature Search and Selection

The literature search period was set to include research literature indexed up to September 3, 2024. Electronic databases searched included PubMed, Embase, MEDLINE, Cochrane Library, CINAHL, PsycInfo, and Web of Science Core Collection. Search keywords are listed in Supplementary Table 1. Although this study targeted only randomized controlled pre-post experimental designs and quasi-experimental studies, searches were conducted specifying that keywords should be included in the title and abstract. When simultaneous title and abstract searches were not possible, searches were performed based on abstract conditions.

4. Data Assessment

Quality assessment was independently conducted using checklists by two researchers experienced in systematic reviews and meta-analyses, along with one additional researcher. To enhance assessment consistency, two practice sessions were conducted using the assessment tools. When disagreements occurred, additional quality assessments were performed through meetings until consensus was reached among researchers to derive agreed-upon results.

For quality assessment of literature, randomized comparative studies were evaluated using the Cochrane Collaboration’s Revised Risk of Bias tool for randomized trials (RoB 2.0), assessing five items: bias arising from the randomization process, bias due to deviations from intended interventions, bias due to missing outcome data, bias in measurement of the outcome, and bias in selection of the reported result. Non-randomized comparative studies were evaluated using the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool, assessing seven items: confounding bias, selection bias, intervention classification bias, bias due to deviations from intended interventions, bias due to missing data, outcome measurement bias, and selective reporting bias.

The overall risk of bias for RCTs was judged according to the Cochrane Handbook for Systematic Reviews of Interventions. A study was rated as ‘low risk’ only if all domains were assessed as ‘low risk.’ It was rated as ‘some concerns’ if at least one domain was assessed as ‘some concerns,’ with no domains rated as ‘high risk.’ The overall judgment was ‘high risk’ if at least one domain was rated as ‘high risk’ or if the study was judged to have ‘some concerns’ for multiple domains. Our assessment reported in Supplementary Figure 1 accurately follows this principle.

5. Data Analysis

Although meta-analysis is a common method for quantitative synthesis in systematic reviews, it was deemed inappropriate for this study due to the significant heterogeneity observed across the included articles. The sources of heterogeneity were substantial, including: (1) diverse participant populations with varying chronic conditions; (2) wide variations in intervention design, content, and delivery methods (e.g., comprehensive vs. medication-specific); (3) a lack of consistency in reported outcome measures (e.g., medication adherence, clinical indicators like blood pressure, psychosocial indicators like quality of life); and (4) different follow-up durations. Given these conditions, statistically pooling the results could have produced misleading conclusions. Therefore, a structured narrative synthesis, guided by King’s Goal Attainment Theory, was chosen as the most appropriate method to meaningfully synthesize the findings and explore the characteristics of effective programs across different contexts.

Data synthesis was conducted through a theory-driven structured narrative synthesis, systematically analyzing how the four key intervention dimensions related to King’s theoretical framework. Program scope (comprehensive vs. medication-specific) was examined as reflecting the action and reaction phases of the transaction process, representing how healthcare systems recognize and respond to medication management needs. Provider type (nurses, pharmacists, multidisciplinary teams, others) and program duration (single-session vs. multi-session) were analyzed as indicators of the interaction and transaction phases, revealing how different interpersonal dynamics and relationship investments facilitate collaborative goal-setting. Outcome type (clinical vs. psychosocial) served to evaluate goal attainment, assessing whether interventions achieved the health objectives established between providers and patients.

The content aligned with the research objectives was extracted and organized from the finally selected studies using Microsoft Excel. Extracted information included: authors, publication year, country, research design, details of educational interventions (e.g., content, delivery method, number and duration of sessions, frequency of education), participant characteristics (e.g., age, race/ethnicity, gender), authors’ definitions of medication self-management education, and outcome measures (e.g., measurement tools, timing and frequency of measurement).

For the purpose of this review, the primary outcome was defined as medication adherence, which was the most commonly reported clinical indicator of effectiveness. Secondary outcomes included drug-related problems, hospitalization rates, and self-efficacy. The risk of bias assessment for each study was conducted based on the reported results for the primary outcome. If medication adherence was not reported, the assessment was based on the main clinical outcome presented by the study authors.

Data were synthesized descriptively by categorizing studies according to the theoretical framework, with the included studies grouped along the four operationalized dimensions: (1) Program scope (comprehensive vs. medication-specific interventions), (2) outcome type (clinical vs. psychosocial indicators), (3) provider type (multidisciplinary teams, nurses, pharmacists, or other healthcare providers), and (4) program duration (single-session vs. multi-session interventions). This theory-guided categorization enabled analysis of how different intervention characteristics aligned with the personal and interpersonal systems within King’s framework, and how these characteristics contributed to successful transaction processes and goal attainment.

The narrative synthesis examined how each program facilitated the progression from problem recognition (action) through provider-patient communication and collaboration (interaction) to goal achievement (transaction and attainment). Trends, patterns, and gaps were identified within each dimension and across their interactions to provide theoretical insights into the mechanisms of MSEP and inform future research and program development for older adults.

STUDY RESULTS

1. Results of Literature Search and Selection

Literature searches were conducted using advanced search options, with two researchers independently performing searches and comparing search strategies until results matched across databases. Initial search results yielded 684 articles: PubMed (87), Embase (106), MEDLINE (32), Cochrane Library (274), CINAHL (22), PsycInfo (29), and Web of Science (134). After removing 206 duplicate articles using EndNote, 478 articles underwent primary screening of titles and abstracts. At this stage, 361 articles were removed: 144 non-older adult targeted studies, 103 studies not focusing on medication self-management education, 52 studies without control groups, 42 non-experimental studies, two qualitative studies, seven literature reviews and meta-analyses, three articles without full text, and eight duplicates, leaving 117 articles for full-text review.

During full-text review, 101 articles were excluded (Supplementary Table 2): 47 non-older adult targeted studies, 18 studies not focusing on medication self-management education, six single-group studies without control groups, 19 proceedings/procedure studies without research results, eight studies lacking statistical results, two gray literature items without research results, and one without full text. Additionally, 18 articles were added through reference lists and direct searches. Finally, 34 articles were included in the systematic review (Figure 1). The full bibliographic list of included studies (A1~A34) is provided in Appendix 1.

Figure 1.

PRISMA flow diagram.

2. Results of Data Assessment

Of 34 studies, 28 RCTs were assessed using RoB 2.0 [A1-A28], with 11 showing “some concerns” in bias, particularly in D2 (deviations from interventions) and D4 (outcome measurement) (Supplementary Figure 1). Other RCTs had low bias risk. Six non-randomized studies, assessed via ROBINS-I [A29-A34], exhibited moderate bias overall, with low risk in D3 (intervention classification) and D7 (result selection, except [A32]) and moderate bias in D4 for most studies. Other domains showed low to moderate bias (Supplementary Figure 1).

3. Results of General Characteristics of Selected Literature

The general characteristics of the 34 selected studies are shown in Table 1. Furthermore, Table 2 presents a brief summary of the characteristics for each included study, systematically categorized according to King’s theoretical framework operationalization. The studies demonstrated diverse approaches to medication self-management education, reflecting different strategies within the interpersonal and personal systems that contribute to goal attainment.

General Characteristics of the Selected Studies (N=34)

Summary of Intervention Characteristics for Included Studies According to King’s Goal Attainment Theory Framework (N=34)

Regarding publication countries, the United States had the highest number with 12 studies (30.0%), followed by South Korea and Australia with four studies (10.0%) each. Concerning research methodology, RCTs were more prevalent with 28 studies (82.4%) compared to quasi-experimental studies with six studies (17.6%). Study duration varied, with 14 studies (41.2%) lasting 1-2 years and 10 studies (29.4%) lasting less than 1 year. Regarding funding, 27 studies (79.4%) received financial support.

4. Results of Program Scope: Comprehensive vs. Medication-Specific Interventions

Reflecting the action and reaction phases of King’s transaction process, the 34 studies demonstrated two distinct approaches to recognizing and responding to medication management needs in older adults. Twenty studies implemented comprehensive interventions that integrated medication self-management education with broader health-focused components, such as geriatric assessments, chronic disease management, or health counseling. This comprehensive approach represents a broad systemic reaction to complex health needs, as seen in D’Agostino et al. [A1], who employed a multidimensional approach combining geriatric assessment and motivational counseling for older adults in a substance abuse program, and Leveille et al. [A17], who collaborated with social workers to address disability and chronic illness management.

In contrast, 14 studies delivered medication-specific interventions, focusing on adherence, misuse, or specific drug regimens. Examples include Almutairi et al. [A2], which targeted psychotropic medication reduction in aged care residents, and Kim [A15], which provided hypertension-focused education via remote methods. Furthermore, detailed information regarding the medication self-management status of each study is presented in Supplementary Table 3.

5. Results of Outcome Type: Clinical vs. Psychosocial Indicators

The outcome patterns observed across studies reflect different dimensions of goal attainment within King’s framework. Clinical outcomes, observed in 28 studies ([A1,A2,A4-A7,A9-A19,A21,A23-A31,A34]), included measurable health indicators such as medication adherence, blood pressure control, hospitalization rates, and drug-related problems. These clinical indicators represent tangible goal attainment in the physical health domain, as demonstrated by Gohil et al. [A12], who measured reductions in antibiotic days of therapy, and Varas-Doval et al. [A24], who evaluated uncontrolled health problems.

Psychosocial outcomes, reported in 15 studies ([A3,A4,A6,A8,A14,A15,A20,A22,A23,A25-27,A30,A32,A33]), encompassed quality of life, self-efficacy, medication knowledge, and self-management behaviors. These psychosocial indicators reflect goal attainment within the personal system, showing changes in self-concept, knowledge, and capacity for self-management, as seen in Ballard et al. [A3] (quality of life in dementia patients) and Lee [A32] (medication awareness in hypertensive older adults). Nine studies ([A6,A8,A14,A15,A23,A25-27,A30]) assessed both clinical and psychosocial outcomes, demonstrating comprehensive goal attainment across multiple domains. Detailed information on the characteristics of the interventions in MSEP is provided in Supplementary Table 4.

6. Results of Provider Type: Nurses, Pharmacists, and Multidisciplinary Teams

Provider variation represents different patterns of interpersonal system dynamics and transaction processes. Intervention providers varied, with 13 studies led by pharmacists, seven by nurses, six by multidisciplinary teams, and eight by other providers (e.g., physicians, therapists). Pharmacist-led interventions typically embodied technical transaction patterns, with studies such as Lin et al. [A18] and Harlow et al. [A30] focusing on medication reviews and adherence, leveraging pharmacists’ specialized drug expertise for precise, medication-focused interactions.

Nurse-led interventions demonstrated holistic transaction patterns, with studies including Elpida et al. [A8] and Farahmand et al. [A29] emphasizing patient education and self-management through sustained relationship building and continuous engagement. Multidisciplinary teams facilitated complex transaction processes, as seen in Woodham et al. [A34] and Wang et al. [A25], which integrated diverse professional expertise to address multifaceted needs, such as cardiovascular disease management. Other providers included geriatric care managers (D’Agostino et al. [A1]) and physiotherapists (Rios et al. [A23]), representing specialized interaction approaches tailored to specific patient populations. Detailed information on the characteristics of the interventions in MSEP is provided in Supplementary Table 4.

7. Results of Program Duration: Single-Session vs. Multi-Session Interventions

Program duration reflects the depth and intensity of the interaction and transaction phases within the interpersonal system. Of the 34 studies, four implemented single-session interventions, 28 delivered multi-session interventions, and two had unspecified intervention counts (“NI”). Single-session interventions represent concentrated transaction processes, as demonstrated by Almutairi et al. [A2] and Lalonde et al. [A16], which involved focused, one-time education or consultation, often delivered remotely or in specialized settings for specific, well-defined goals.

Multi-session interventions facilitated extended transaction processes, ranging from 2 to 12 sessions and including Ballard et al. [A3] (9 sessions) and Nir and Weisel-Eichler [A22] (12 sessions), emphasizing repeated engagement and relationship development over time. These extended programs enabled iterative goal-setting and achievement cycles, with multi-session programs being particularly prevalent in comprehensive interventions addressing complex conditions like dementia or cardiovascular disease. Detailed information on the characteristics of the interventions in MSEP is provided in Supplementary Table 4.

DISCUSSION

This systematic review synthesizes MSEP for older adults, guided by King’s Goal Attainment Theory [12]. Our finding that MSEP are broadly effective aligns with the conclusions of prior systematic reviews, such as those by Rao and Hung [6] and Christopher et al. [9]. These studies confirmed the positive impact of such interventions on outcomes like medication adherence and the reduction of inappropriate medication use.

However, the unique contribution of our review lies in the application of Imogene King’s Goal Attainment Theory, which provides a novel explanatory framework for why and how these programs work at a level of analysis not present in previous reviews. For example, while prior studies identified multi-session interventions as effective, our analysis, framed by King’s concepts of ‘interaction’ and ‘transaction’, posits that their success stems from the iterative, collaborative goal-setting process that reinforces patient learning and engagement over time. This theoretical insight into the mechanism of effectiveness is a key contribution that moves beyond descriptive findings.

Furthermore, like the scoping review by Kurczewska-Michalak et al. [7], we also identified significant heterogeneity in intervention design. While their work mapped this diversity, our theory-guided analysis helps to organize and interpret it. For instance, our findings suggest that pharmacist-led, medication-specific interventions strongly align with King’s ‘action’ component by efficiently targeting discrete clinical goals, whereas nurse-led, comprehensive programs better reflect the ‘interaction’ process by addressing broader, complex psychosocial needs. This framework provides a structured explanation for the observed heterogeneity and offers clear guidance on matching program types to specific goals, thereby adding significant value beyond existing literature. It categorizes 34 studies by intervention, outcome, provider, and duration, highlighting diverse approaches to improve self-management and inform tailored interventions for polypharmacy.

Within King’s personal and interpersonal systems framework, we analyzed program scope as a proxy for the ‘action/reaction’ phase of the transaction process, representing how healthcare systems recognize individual patient needs (personal system) and formulate strategic responses through provider-patient interactions (interpersonal system). Comprehensive interventions, implemented in 20 studies, integrated medication education with broader health components, such as geriatric assessments or chronic disease management [A1,A5,A7,A9,A11,A13,A14,A17,A18,A20,A22-28,A30,A31,A34]. These programs align with King’s interaction and transaction components, fostering collaborative goal-setting to address complex health needs across multiple personal system domains (perception, self-concept, growth and development). For example, D’Agostino et al. [A1] combined geriatric assessment with motivational counseling, targeting substance abuse in older adults through comprehensive interpersonal system engagement. In contrast, medication-specific interventions, used in 14 studies, focused on adherence or specific drug regimens, such as psychotropic reduction or antihypertensive management [A2-4,A6,A8,A10,A12,A15,A16,A19,A21,A29,A32,A33]. These align with focused action and reaction within the interpersonal system, initiating targeted engagement around specific personal system medication-related needs, as seen in Almutairi et al. [A2], which reduced psychotropic use in aged care residents. Comprehensive programs were prevalent among community-dwelling older adults with multiple conditions [A7,A9,A18,A26-28,A31,A33,A34], while medication-specific programs targeted conditions like hypertension or heart failure [A8,A15,A29,A31,A32]. However, some medication-specific interventions addressed broader outcomes (e.g., QALYs in Jódar-Sánchez et al. [A14]), suggesting overlap with comprehensive approaches and demonstrating that targeted interpersonal system interventions can still achieve holistic personal system changes. This overlap challenges the assumption that comprehensive programs are inherently more holistic, as targeted interventions may achieve similar goals with greater efficiency [A2,A15].

The ‘goal attainment’ component of the theory was evaluated by analyzing the types of outcomes reported. The studies reported clinical outcomes in 28 studies, psychosocial outcomes in 15, and both in nine, reflecting diverse evaluation metrics [A1-34]. Clinical outcomes, such as medication adherence, blood pressure control, and reduced hospitalizations, were prominent in medication-specific interventions [A1,A2,A4-7,A9-19,A21,A23-A31,A34]. For instance, Gohil et al. [A12] reduced antibiotic therapy duration, and Varas-Doval et al. [A24] addressed uncontrolled health problems. These outcomes reflect King’s Goal Attainment, driven by structured transactions like adherence-focused education. Psychosocial outcomes, including quality of life, self-efficacy, and medication knowledge, were common in comprehensive programs [A3,A4,A8,A14,A15,A20,A22,A23,A25-27,A30,A33,A34]. Ballard et al. [A3] improved quality of life in dementia patients, and Lee [A32] enhanced medication awareness in hypertensive older adults. These align with interaction and reaction, emphasizing behavioral changes through collaborative goal-setting. Studies targeting both outcomes, such as Elpida et al. [A6,A8,A14,A15,A23,A25-27,A30], balanced clinical (e.g., adherence) and psychosocial (e.g., heart failure knowledge) goals but often required complex designs to address multiple domains. Outcomes like “medication misuse behavior” in Park et al. [A33] were classified as psychosocial, consistent with behavioral metrics, though future studies should clarify potential clinical overlaps to reduce classification uncertainties.

The ‘interaction’ phase operates primarily within the interpersonal system, where provider and patient characteristics from their respective personal systems (individual expertise, beliefs, and capacities) come together to create collaborative relationships. This interpersonal system dynamic was examined through the lens of provider type. Intervention providers varied, with pharmacists leading 13 studies, nurses seven, multidisciplinary teams six, and other providers (e.g., physicians, therapists) eight [A1-34]. Pharmacist-led interventions brought specific personal system attributes (technical medication expertise, analytical skills) into the interpersonal system, focusing on medication reviews and adherence [A2,A7,A10,A14,A16,A18,A19,A21,A24,A26,A27,A30,A31]. For example, Lin et al. [A18] addressed polypharmacy in older adults with chronic diseases. These align with King’s action component, emphasizing technical management through structured interpersonal transactions. Nurse-led interventions leveraged different personal system characteristics (holistic care perspective, relationship-building skills) within the interpersonal system, emphasizing patient education and self-management, fostering continuous engagement [A8,A9,A15,A17,A29,A32,A33]. Elpida et al. [A8] improved heart failure knowledge through nurse-led education. These align with interaction and transaction, building trust and collaborative goals through sustained interpersonal system development. Multidisciplinary teams represented the integration of multiple personal systems (diverse professional expertise and perspectives) within expanded interpersonal system networks, addressing complex needs, such as cardiovascular management in Wang et al. [A25] [A11,A12,A13,A25,A28,A34]. Other providers, like geriatric care managers in D’Agostino et al. [A1], addressed unique populations by bringing specialized personal system knowledge into tailored interpersonal system approaches [A1,A3,A4,A6,A20,A22,A23]. Multidisciplinary and nurse-led interventions were common in comprehensive programs, while pharmacist-led interventions focused on medication-specific interventions, reflecting how different personal system attributes optimize specific types of interpersonal system transactions. However, single-provider interventions (e.g., pharmacist-led intervention [A16]) may be more efficient for specific goals, challenging the assumption that multidisciplinary teams are always superior.

Finally, the ‘transaction’ component represents the culmination of personal system readiness (individual motivation and capacity) and interpersonal system development (provider-patient relationship quality) within the broader social system context (healthcare organizational support). This structured exchange over time to achieve goals was assessed via program duration. Program duration analysis revealed four single-session, 28 multi-session, and two unspecified interventions [A1-34]. Single-session interventions reflected immediate personal system activation and focused interpersonal system transactions within existing social system constraints, often delivered remotely or in focused settings, targeting immediate outcomes like drug-related problems [A2,A12,A14-17,A19]. Lalonde et al. [A16] addressed chronic kidney disease with one-time education. These align with action and reaction, initiating change when personal system readiness is high and social system support is limited. Multi-session interventions facilitated progressive personal system development and deeper interpersonal system relationship building within supportive social system frameworks, ranging from 2 to 12 sessions and emphasizing repeated engagement for complex conditions like dementia or cardiovascular disease [A1,A3,A4,A6,A8,A9-11,A21-27,A29,A30,A32-34]. Ballard et al. [A3] used nine sessions to improve quality of life. These align with transaction, reinforcing learning through iterative feedback that strengthens both personal system capacity and interpersonal system collaboration over time. Multi-session programs were associated with behavioral outcomes (e.g., self-efficacy [A25]), reflecting deeper personal system changes, while single-session programs suited clinical outcomes (e.g., adherence [A15]), indicating focused interpersonal system transactions. However, single-session interventions may suffice for well-defined goals, as in Kim [A15], when personal system readiness is optimal and social system resources are efficiently utilized, challenging the assumption that more sessions are always better. Unspecified intervention counts in two studies [A28,A31] introduced uncertainty, limiting conclusions about optimal duration and the interplay between personal, interpersonal, and social system factors over time.

The integration of King’s three interacting systems provides a comprehensive understanding of intervention effectiveness across multiple dimensions. At the personal system level, comprehensive programs addressing both medication knowledge and self-management skills demonstrated superior outcomes, as individuals require holistic support for their unique health challenges and cognitive capabilities. The interpersonal system analysis revealed that pharmacist-led interventions achieved optimal effectiveness through their specialized medication expertise and established patient relationships, while multi-disciplinary approaches leveraged diverse professional perspectives to address complex patient needs through structured collaborative transactions. At the social system level, multi-session programs created sustained support networks and reinforced learning environments, enabling progressive goal achievement through repeated interactions and adaptive intervention strategies. This systems integration demonstrates that medication self-management education effectiveness emerges not from isolated program components, but from the dynamic interplay between individual patient characteristics, professional relationships, and broader healthcare system structures. The theory’s transaction process framework particularly illuminated how successful interventions facilitate action-reaction cycles between patients and providers, leading to meaningful interactions that culminate in measurable goal attainment across clinical and psychosocial outcomes.

These findings have practical implications for designing MSEP. Comprehensive programs suit older adults with multiple chronic conditions, leveraging multidisciplinary teams to address holistic needs [A1,A5,A17,A25,A34]. Medication-specific programs are effective for targeted conditions such as hypertension, using pharmacists or nurses for efficiency [A2,A8,A15,A29,A32]. Programs should balance clinical and psychosocial outcomes, as both enhance health and well-being [A8,A32]. Multi-session interventions are ideal for behavioral changes, but single-session programs can address immediate needs, especially in resource-limited settings [A2,A15]. Remote and hybrid interventions (e.g., online monitoring [A13,A14,A29]) improve accessibility for mobility-constrained older adults, but digital literacy training is needed, as older adults may struggle with technology [16]. Caregiver education, including tools like pill organizers and telehealth support, can enhance home-based management, particularly for those with cognitive decline [17].

The findings of this review offer several practical implications for different stakeholders. For clinicians and program designers, our results support a tailored approach: comprehensive, multi-session programs delivered by multidisciplinary teams are ideal for patients with complex health needs and psychosocial goals, whereas pharmacist-led, medication-specific interventions can efficiently improve clinical outcomes like adherence for targeted conditions. For policymakers, this review highlights the need to support the integration of multidisciplinary care models in primary care and to strengthen training programs for nurses and pharmacists in medication education, ensuring that effective programs can be scaled sustainably. For future research, it is clearly imperative to develop and test standardized interventions for underrepresented populations, such as long-term care residents, and to adopt consistent outcome measures to facilitate future meta-analyses.

Several limitations must be acknowledged. The heterogeneity in intervention designs, outcome measures, and participant characteristics (e.g., limited race/ethnicity data in 29 studies) complicates direct comparisons. Short follow-up periods in 10 studies (<12 months) limit evidence of long-term sustainability. Unspecified intervention details (e.g., “NI” in 2 studies) introduced classification uncertainties. The search strategy, conducted without a librarian, may have missed relevant studies, risking publication bias. Excluding non-experimental studies and gray literature may have limited the review’s scope. These limitations align with King’s theory, as incomplete data hinders effective goal-setting and transaction.

Future research should standardize intervention components, outcome measures, and follow-up durations to enhance comparability. Studies targeting long-term care residents, underrepresented in this review [A2,A3], are needed to address their unique barriers, such as cognitive decline. Incorporating caregivers and digital health tools [17] could improve program scalability. Larger, diverse studies with longer follow-ups are essential to evaluate sustained outcomes, such as reduced hospitalizations. Alternative theoretical frameworks, like Social Cognitive Theory, could complement King’s theory by emphasizing self-efficacy. From a policy perspective, strengthening nurse and pharmacist training in medication education, and integrating multidisciplinary care models, will support scalable, culturally sensitive programs for older adults.

CONCLUSION

This systematic review confirms that MSEP are a valuable tool for enhancing adherence and reducing inappropriate medication use among older adults. By analyzing these programs through the lens of King’s Goal Attainment Theory, this review concludes that their success is not merely informational but procedural; interventions that explicitly fostered interaction and transaction through collaborative, multi-session formats were most effective at achieving complex goals. Comprehensive programs excelled at achieving psychosocial goals through rich provider-patient interactions, while targeted, medication-specific interventions were efficient at achieving clinical goals through direct action. While our review confirms the value of these approaches, it also highlights a significant evidence gap concerning residents in long-term care. Therefore, a key implication is the need for future research to design and test standardized programs that integrate digital tools and caregivers to support the goal attainment process in these specific, high-need populations.

Notes

Authors' contribution

Conceptualization - EJK and SKK; Data curation - EJK, SKK, BNP, GWJ, and YSR; Formal analysis - EJK and SKK; Investigation - EJK, SKK, BNP, GWJ, and YSR; Methodology - EJK and SKK; Project administration - EJK and SKK; Supervision - EJK and SKK; Writing–original draft - BNP, GWJ, and YSR; Writing–review & editing - EJK and SKK. All authors contributed to the literature screening process. All authors read and approved of the final manuscript.

Conflict of interest

No existing or potential conflict of interest relevant to this article was reported.

Funding

This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (No. 2021R1A2C1095530).

Data availability

Please contact the corresponding author for data availability.

Acknowledgements

None.

Supplementary materials

Supplementary Table 1.

Presenting the PICOTS-SD Process Applied in the Screening Step

jkgn-2025-00171-Supplementary-Table-1.pdf
Supplementary Table 2.

The List of Studies Excluded at the Full-Text Review Stage

jkgn-2025-00171-Supplementary-Table-2.pdf
Supplementary Table 3.

Characteristics of Study Participants in Selected Literature (N=34)

jkgn-2025-00171-Supplementary-Table-3.pdf
Supplementary Table 4.

Characteristics of Interventions in Medication Management Education Programs for Older Adults (N=34)

jkgn-2025-00171-Supplementary-Table-4.pdf
Supplementary Figure 1.

Risk-of-bias assessment.

jkgn-2025-00171-Supplementary-Fig-1.pdf

References

1. Organisation for Economic Co-operation and Development (OECD). Health at a Glance 2021: OECD Indicators [Internet]. OECD; 2021 Nov 9 [cited 2024 Oct 17]. Available from: https://doi.org/10.1787/ae3016b9-en.
2. Johns Hopkins Medicine. Polypharmacy in adults 60 and older [Internet]. Johns Hopkins Medicine; 2024 Mar 11 [cited 2024 Oct 17]. Available from: https://www.hopkinsmedicine.org/health/wellness-and-prevention/polypharmacy-in-adults-60-and-older.
3. Varga S, Alcusky M, Keith SW, Hegarty SE, Del Canale S, Lombardi M, et al. Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults. British Journal of Clinical Pharmacology 2017;83(11):2572–80. https://doi.org/10.1111/bcp.13365. 10.1111/bcp.13365. 28667818.
4. Hales CM, Servais J, Martin CB, Kohen D. Prescription drug use among adults aged 40-79 in the United States and Canada [Internet]. National Center for Health Statistics; 2019 Aug [cited 2024 Oct 17]. Available from: https://www.cdc.gov/nchs/products/databriefs/db347.htm.
5. Lau S, Lun P, Ang W, Tan KT, Ding YY. Barriers to effective prescribing in older adults: applying the theoretical domains framework in the ambulatory setting - a scoping review. BMC Geriatrics 2020;20(1):459. https://doi.org/10.1186/s12877-020-01766-7. 10.1186/s12877-020-01766-7. 33167898.
6. Rao P, Hung A. Impact of medication therapy management programs on potentially inappropriate medication use in older adults: a systematic review. Journal of Managed Care & Specialty Pharmacy 2024;30(1):3–14. https://doi.org/10.18553/jmcp.2024.30.1.03. 10.18553/jmcp.2024.30.1.03. 38153866.
7. Kurczewska-Michalak M, Lewek P, Jankowska-Polańska B, Giardini A, Granata N, Maffoni M, et al. Polypharmacy management in the older adults: a scoping review of available interventions. Frontiers in Pharmacology 2021;12:734045. https://doi.org/10.3389/fphar.2021.734045. 10.3389/fphar.2021.734045. 34899294.
8. Yang C, Lee DTF, Wang X, Chair SY. Effects of a nurse-led medication self-management intervention on medication adherence and health outcomes in older people with multimorbidity: a randomised controlled trial. International Journal of Nursing Studies 2022;134:104314. https://doi.org/10.1016/j.ijnurstu.2022.104314. 10.1016/j.ijnurstu.2022.104314. 35849886.
9. Christopher CM, Kc B, Blebil A, Alex D, Ibrahim MIM, Ismail N, et al. Clinical and humanistic outcomes of community pharmacy-based healthcare interventions regarding medication use in older adults: a systematic review and meta-analysis. Healthcare (Basel) 2021;9(11):1577. https://doi.org/10.3390/healthcare9111577. 10.3390/healthcare9111577. 34828622.
10. Marseille BR, Commodore-Mensah Y, Davidson PM, Baker D, D’Aoust R, Baptiste DL. Improving hypertension knowledge, medication adherence, and blood pressure control: a feasibility study. Journal of Clinical Nursing 2021;30(19-20):2960–7. https://doi.org/10.1111/jocn.15803. 10.1111/jocn.15803. 33872425.
11. Ukoha-Kalu BO, Isah A, Biambo AA, Samaila A, Abubakar MM, Kalu UA, et al. Effectiveness of educational interventions on hypertensive patients' self-management behaviours: an umbrella review protocol. BMJ Open 2023;13(8):e073682. https://doi.org/10.1136/bmjopen-2023-073682. 10.1136/bmjopen-2023-073682. 37550030.
12. King IM. King’s theory of goal attainment. Nursing Science Quarterly 1992;5(1):19–26. https://doi.org/10.1177/089431849200500107. 10.1177/089431849200500107. 1538850.
13. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions version 6.5 [Internet]. Cochrane; 2024 [updated 2024 Aug; cited 2024 Oct 17]. Available from: www.cochrane.org/handbook.
14. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71. 10.1136/bmj.n71. 33782057.
15. Organisation for Economic Co-operation and Development (OECD). Elderly population [Internet]. OECD; [cited 2024 Oct 17]. Available from: https://data.oecd.org/pop/elderly-population.htm.
16. An C. Exploring the impact of smart mobility and ICT solutions on older adults’ mobility: a systematic literature review. IEEE Access 2024;12:159056–69. https://doi.org/10.1109/ACCESS.2024.3487113. 10.1109/ACCESS.2024.3487113.
17. Choukou MA, Olatoye F, Urbanowski R, Caon M, Monnin C. Digital health technology to support health care professionals and family caregivers caring for patients with cognitive impairment: scoping review. JMIR Mental Health 2023;10:e40330. https://doi.org/10.2196/40330. 10.2196/40330. 36630174.

Appendices

Appendix 1 List of Studies Included in a Systematic Review

Article information Continued

Figure 1.

PRISMA flow diagram.

Table 1.

General Characteristics of the Selected Studies (N=34)

Characteristic Number %
Publication year From 1994 to 2005 5 14.7
From 2006 to 2015 12 35.3
From 2016 to 2024 17 50.0
Region* North America (n=13) Canada 1 2.5
USA 12 30.0
South America (n=1) Brazil 1 2.5
Europe (n=5 studies; 11 countries represented) Croatia 1 2.5
Denmark 1 2.5
Germany 1 2.5
Greece 1 2.5
Netherlands 1 2.5
Northern Ireland 1 2.5
Portugal 1 2.5
Republic of Ireland 1 2.5
Spain 1 2.5
Sweden 1 2.5
UK 1 2.5
Asia (n=10) China 1 2.5
Israel 1 2.5
Iran 1 2.5
South Korea 4 10.0
Taiwan 2 5.0
Thailand 1 2.5
Oceania (n=5) Australia 4 10.0
New Zealand 1 2.5
Study design Randomized controlled trial study 28 82.4
Quasi-experimental study 6 17.6
Study duration (year) <1 10 29.4
1~2 14 41.2
>2 1 2.9
Not specified 9 26.5
Funding Yes 27 79.4
No 7 20.6
*

The categories ‘UK’, ‘Northern Ireland’, and ‘Republic of Ireland’ were retained separately to accurately reflect the exact geographical locations as reported in the original included studies. UK=United Kingdom; USA=United States of America.

Table 2.

Summary of Intervention Characteristics for Included Studies According to King’s Goal Attainment Theory Framework (N=34)

Reference No. Study (author, year) Program scope Outcome type Provider type Program duration
A1 D’Agostino et al. (2006) Comprehensive Clinical Other Multi-session
A2 Almutairi et al. (2023) Medication-Specific Clinical Pharmacist Single-session
A3 Ballard et al. (2018) Medication-Specific Psychosocial Other Multi-session
A4 Buist et al. (2006) Medication-Specific Psychosocial Physician Multi-session
A5 Chia-Ming et al. (2010) Comprehensive Clinical MDT Multi-session
A6 Goeman et al. (2013) Medication-Specific Both Other Multi-session
A7 Elliott et al. (2012) Comprehensive Clinical Pharmacist Multi-session
A8 Elpida et al. (2021) Medication-Specific Both Nurse Multi-session
A9 Fabacher et al. (1994) Comprehensive Clinical Nurse Multi-session
A10 Falamić et al. (2018) Medication-Specific Clinical Pharmacist Multi-session
A11 Fung et al. (2024) Comprehensive Clinical Other Multi-session
A12 Gohil et al. (2024) Medication-Specific Clinical MDT Single-session
A13 Hess et al. (2024) Comprehensive Clinical MDT Multi-session
A14 Jódar-Sánchez et al. (2015) Comprehensive Both Pharmacist Multi-session
A15 Kim (2019) Medication-Specific Both Nurse Single-session
A16 Lalonde et al. (2017) Medication-Specific Clinical Pharmacist Single-session
A17 Leveille et al. (1998) Comprehensive Clinical Nurse Multi-session
A18 Lin et al. (2018) Comprehensive Clinical MDT Multi-session
A19 Meredith et al. (2002) Medication-Specific Clinical Pharmacist Multi-session
A20 Morgan et al. (2012) Comprehensive Psychosocial Other Multi-session
A21 Naunton (2003) Medication-Specific Clinical Pharmacist Multi-session
A22 Nir and Weisel-Eichler (2006) Comprehensive Psychosocial Other Multi-session
A23 Rios et al. (2020) Comprehensive Both Other Multi-session
A24 Varas-Doval et al. (2020) Comprehensive Clinical Pharmacist Multi-session
A25 Wang et al. (2021) Comprehensive Both MDT Multi-session
A26 Bernsten et al. (2001) Comprehensive Both Pharmacist Multi-session
A27 Bryant et al. (2010) Comprehensive Both Pharmacist Multi-session
A28 Touchette et al. (2012) Comprehensive Clinical Pharmacist NI
A29 Farahmand et al. (2019) Medication-Specific Clinical Nurse Multi-session
A30 Harlow et al. (2017) Comprehensive Both Pharmacist Multi-session
A31 Son et al. (2019) Comprehensive Clinical Pharmacist NI
A32 Lee (2013) Medication-Specific Psychosocial Nurse Multi-session
A33 Park et al. (2014) Medication-Specific Psychosocial Nurse Multi-session
A34 Woodham et al. (2020) Comprehensive Clinical MDT Multi-session

This classification reflects King’s Goal Attainment Theory operationalization: Program scope represents the action/reaction phases - ‘comprehensive’ indicates broad systemic responses integrating medication education with health components; ‘medication-specific’ indicates focused responses targeting specific medication issues. Provider type and program duration reflect interpersonal system dynamics - different provider types represent varied interaction patterns, while duration indicates transaction depth and relationship development intensity. Outcome type represents goal attainment dimensions - ‘clinical’ refers to measurable health indicators; ‘psychosocial’ refers to personal system changes in self-concept and capacity; ‘both’ indicates comprehensive goal achievement across multiple domains. MDT=Multidisciplinary team; Other=Includes professionals not categorized as nurses, pharmacists, or part of an explicit MDT, such as physicians, therapists, geriatric care managers, trained advisers, and nursing students, or when the provider was not specified in the study; NI=No information was available in the study regarding the specific number of intervention sessions.

No. Literature
A1 D’Agostino CS, Barry KL, Blow FC, Podgorski C. Community interventions for older adults with comorbid substance abuse: the geriatric addictions program (gap). Journal of Dual Diagnosis. 2006;2(3):31-45. https://doi.org/10.1300/J374v02n03_04
A2 Almutairi H, Stafford A, Etherton-Beer C, Fitzgerald P, Flicker L. Impact of a multifaceted, pharmacist-led intervention on psychotropic medication use for residents of aged care facilities: a parallel cluster randomized controlled trial. Journal of the American Medical Directors Association. 2023;24(9):1311.e1-8. https://doi.org/10.1016/j.jamda.2023.06.037
A3 Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, et al. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial. Plos Medicine. 2018;15(2):e1002500. https://doi.org/10.1371/journal.pmed.1002500
A4 Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD, Buist AS, et al. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. American Journal of Respiratory and Critical Care Medicine. 2006;174(10):1077-87. https://doi.org/10.1164/rccm.200510-1606OC
A5 Li CM, Chen CY, Li CY, Wang WD, Wu SC. The effectiveness of a comprehensive geriatric assessment intervention program for frailty in community-dwelling older people: a randomized, controlled trial. Archives of Gerontology and Geriatrics. 2010;50:S39-42. https://doi.org/10.1016/S0167-4943(10)70011-X
A6 Goeman D, Jenkins C, Crane M, Paul E, Douglass J. Educational intervention for older people with asthma: a randomised controlled trial. Patient Education and Counseling. 2013;93(3):586-95. https://doi.org/10.1016/j.pec.2013.08.014
A7 Elliott RA, Martinac G, Campbell S, Thorn J, Woodward MC. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study. Drugs & Aging. 2012;29:593-605. https://doi.org/10.1007/bf03262276
A8 Elpida K, Constantinos PH, Ioannis V, Athena K, Sotirios K, Eleftherios K, et al. A constructivist approach to teaching patients with heart failure: results from an intervention study. European Journal of Cardiovascular Nursing. 2021;20(4):331-41. https://doi.org/10.1093/eurjcn/zvaa003
A9 Fabacher D, Josephson K, Pietruszka F, Linderborn K, Rubenstein LZ, Morley JE. An in‐home preventive assessment program for independent older adults: a randomized controlled trial. Journal of the American Geriatrics Society. 1994;42(6):630-8. https://doi.org/10.1111/j.1532-5415.1994.tb06862.x
A10 Falamić S, Lucijanić M, Hadžiabdić MO, Marušić S, Bačić Vrca V. Pharmacist’s interventions improve time in therapeutic range of elderly rural patients on warfarin therapy: a randomized trial. International Journal of Clinical Pharmacy. 2018;40:1078-85. https://doi.org/10.1007/s11096-018-0691-z
A11 Fung CH, Alessi C, Martin J, Josephson K, Kierlin L, Dzierzewski J, et al. 0399 Masked tapering and augmented cbti improves benzodiazepine receptor agonist discontinuation in a randomized trial. Sleep. 2024;47(Suppl 1): A171-2. https://doi.org/10.1093/sleep/zsae067.0399
A12 Gohil SK, Septimus E, Kleinman K, Varma N, Avery TR, Heim L, et al. Stewardship prompts to improve antibiotic selection for pneumonia: the inspire randomized clinical trial. JAMA. 2024;331(23):2007-17. https://doi.org/10.1001/jama.2024.6248
A13 Hess CN, Daffron A, Nehler MR, Morrison JT, Buchanan CE, Szarek M, et al. Randomized trial of a vascular care team vs education for patients with peripheral artery disease. Journal of the American College of Cardiology. 2024;83(25):2658-70. https://doi.org/10.1016/j.jacc.2024.04.034
A14 Jódar-Sánchez F, Malet-Larrea A, Martín JJ, García-Mochón L, López del Amo MP, Martínez-Martínez F, et al. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. Pharmacoeconomics. 2015;33:599-610. https://doi.org/10.1007/s40273-015-0270-2
A15 Kim MS. Effects of customized long-message service and phone-based health-coaching on elderly people with hypertension. Iranian Journal of Public Health. 2019;48(4):655-63. https://doi.org/10.18502/ijph.v48i4.986
A16 Lalonde L, Quintana-Bárcena P, Jouini G, Azar J, Martin É, Berbiche D, et al. Community pharmacist training-and-communication network and drug-related problems in patients with ckd: a multicenter, cluster-randomized, controlled trial. American Journal of Kidney Diseases. 2017;70(3):386-96. https://doi.org/10.1053/j.ajkd.2017.05.008
A17 Leveille SG, Wagner EH, Davis C, Grothaus L, Wallace J, LoGerfo M, et al. Preventing disability and managing chronic illness in frail older adults: a randomized trial of a community‐based partnership with primary care. Journal of the American Geriatrics Society. 1998;46(10):1191-8. https://doi.org/10.1111/j.1532-5415.1998.tb04533.x
A18 Lin HW, Lin CH, Chang CK, Chou CY, Yu IW, Lin CC, et al. Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: a prospective, randomized, controlled trial. Journal of the Formosan Medical Association. 2018;117(3):235-43. https://doi.org/10.1016/j.jfma.2017.04.017
A19 Meredith S, Hall K, Arnold K, Ray WA, Brown NJ, Feldman P, et al. A. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. Journal of the American Geriatrics Society. 2002;50(9):1484-91. https://doi.org/10.1046/j.1532-5415.2002.50402.x
A20 Morgan K, Gregory P, Tomeny M, David BM, Gascoigne C. Self‐help treatment for insomnia symptoms associated with chronic conditions in older adults: a randomized controlled trial. Journal of the American Geriatrics Society. 2012;60(10):1803-10. https://doi.org/10.1111/j.1532-5415.2012.04175.x
A21 Naunton M, Peterson GM. Evaluation of home‐based follow‐up of high‐risk elderly patients discharged from hospital. Journal of Pharmacy Practice and Research. 2003;33(3):176-82. https://doi.org/10.1002/jppr2003333176
A22 Nir Z, Weisel-Eichler A. Improving knowledge and skills for use of medication by patients after stroke: evaluation of a nursing intervention. American Journal of Physical Medicine & Rehabilitation. 2006;85(7):582-92. https://doi.org/10.1097/01.phm.0000223227.51120.4d
A23 Rios JCS, Hua FY, Safons MP. Posture-focused self-management programme improves pain and function in older people with chronic low back pain: a randomised controlled trial. International Journal of Therapy and Rehabilitation. 2020;27(4):1-10. https://doi.org/10.12968/ijtr.2018.0082
A24 Varas-Doval R, Gastelurrutia MA, Benrimoj SI, Martinez-Martínez F, García-Cárdenas V, Sáez-Benito L. Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: a cluster randomized controlled trial. Pharmacy Practice (Granada). 2020;18(4):1-8. https://doi.org/10.18549/PharmPract.2020.4.2133
A25 Wang W, Lin B, Zhang Z, Zhang H. Feasibility of a patient engagement and medication safety management program for older adults suffering cardiovascular disease in community settings. Medicine. 2021;100(21):E26125. https://doi.org/10.1097/MD.0000000000026125
A26 Bernsten C, Björkman I, Caramona M, Crealey G, Frøkjær B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs & Aging. 2001;18(1):63-77. https://doi.org/10.2165/00002512-200118010-00005
A27 Bryant LJM, Coster G, Gamble GD, McCormick RN. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. International Journal of Pharmacy Practice. 2011;19(2):94-105. https://doi.org/10.1111/j.2042-7174.2010.00079.x
A28 Touchette DR, Masica AL, Dolor RJ, Schumock GT, Choi YK, Kim Y, et al. Safety-focused medication therapy management: a randomized controlled trial. Journal of the American Pharmacists Association. 2012;52(5):603-12. https://doi.org/10.1331/JAPhA.2012.12036
A29 Farahmand F, Khorasani P, Shahriari M. Effectiveness of a self-care education program on hypertension management in older adults discharged from cardiac-internal wards. ARYA Atherosclerosis. 2019;15(2):44-52. https://doi.org/10.22122/arya.v15i2.1787
A30 Harlow C, Hanna C, Eckmann L, Gokun Y, Zanjani F, Blumenschein K, et al. Quality of life and medication adherence of independently living older adults enrolled in a pharmacist-based medication management program. Pharmacy. 2017;5(2):20. https://doi.org/10.3390/pharmacy5020020
A31 Son KJ, Son HR, Park B, Kim HJ, Kim CB. A community-based intervention for improving medication adherence for elderly patients with hypertension in Korea. International Journal of Environmental Research and Public Health. 2019;16(5):721. https://doi.org/10.3390/ijerph16050721
A32 Lee JK. Evaluation of a medication self-management education program for elders with hypertension living in the community. Korean Society of Nursing Science. 2013;43(2):267-75. https://doi.org/10.4040/jkan.2013.43.2.267
A33 Park YI, Lee KY, Kim DO, Uhm DC, Kim JH. Medication status and the effects of a medication management education program for the elderly in a community. Journal of Korean Academy of Community Health Nursing. 2014;25(3):170-79. https://doi.org/10.12799/jkachn.2014.25.3.170
A34 Woodham NS, Taneepanichskul S, Somrongthong R, Kitsanapun A, Sompakdee B. Effectiveness of a multidisciplinary approach intervention to improve blood pressure control among elderly hypertensive patients in rural Thailand: a quasi-experimental study. Journal of Multidisciplinary Healthcare. 2020;13:571-80. https://doi.org/10.2147/JMDH.S254286